Page last updated: 2024-12-06

sulfaproxyline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

sulfaproxyline: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID67002
CHEMBL ID2107520
SCHEMBL ID149839
MeSH IDM0149166

Synonyms (47)

Synonym
nsc-120646
sulfaproxylin
p-[(4-isopropoxybenzoyl)amino]benzenesulfonamide
n(sup1)-(4-isopropoxybenzoyl)sulfanilamide
benzamide, n-[(4-aminophenyl)sulfonyl]-4-(1-methylethoxy)-
n(sup1)-(4-isopropoxybenzoyl)-p-aminobenzenesulfonamide
116-42-7
p-isopropoxy-n-sulfanilylbenzamide
sulfaproxyline
benzamide, p-isopropoxy-n-sulfanilyl-
sulphaproxyline
n(sup1)-(p-isopropoxybenzoyl)sulfanilamide
nsc120646
g 13289
n-(4-aminophenyl)sulfonyl-4-propan-2-yloxybenzamide
p-((4-isopropoxybenzoyl)amino)benzenesulfonamide
sulfaproxilina [inn-spanish]
sulfaproxylinum
nsc 120646
sulfaproxylinum [inn-latin]
g 14289
n1-(4-isopropoxybenzoyl)sulfanilamide
einecs 204-140-5
benzamide, n-((4-aminophenyl)sulfonyl)-4-(1-methylethoxy)-
sulfaproxilina
sulfaproxyline [inn:ban]
n(sup 1)-(4-isopropoxybenzoyl)sulfanilamide
yr841r53vw ,
unii-yr841r53vw
CHEMBL2107520
SCHEMBL149839
sulfaproxyline [who-dd]
sulfaproxyline [mi]
sulfaproxyline [inn]
sulfaproxylin;sulfaproxyline
HY-101829
sulfaproxiline
CS-6583
AS-70510
n-(4-aminobenzenesulfonyl)-4-(propan-2-yloxy)benzamide
n-(4-aminobenzene-1-sulfonyl)-4-[(propan-2-yl)oxy]benzamide
DTXSID70861746
Q27294674
D92833
EX-A4500
AKOS037646728
n-((4-aminophenyl)sulfonyl)-4-isopropoxybenzamide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]